Nuran Wireless Inc.

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, CSCO.NE has a market cap of 623.1B. Regarding current trading prices, NUR.CN is priced at CA$5.30, while CSCO.NE trades at CA$57.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas CSCO.NE's P/E ratio is 46.73. In terms of profitability, NUR.CN's ROE is +0.64%, compared to CSCO.NE's ROE of +0.24%. Regarding short-term risk, NUR.CN is more volatile compared to CSCO.NE. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check CSCO.NE's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, MAXR.TO has a market cap of 5.3B. Regarding current trading prices, NUR.CN is priced at CA$5.30, while MAXR.TO trades at CA$70.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas MAXR.TO's P/E ratio is -25.65. In terms of profitability, NUR.CN's ROE is +0.64%, compared to MAXR.TO's ROE of -0.11%. Regarding short-term risk, NUR.CN is more volatile compared to MAXR.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check MAXR.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, ET.TO has a market cap of 1.2B. Regarding current trading prices, NUR.CN is priced at CA$5.30, while ET.TO trades at CA$16.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas ET.TO's P/E ratio is 20.40. In terms of profitability, NUR.CN's ROE is +0.64%, compared to ET.TO's ROE of +0.25%. Regarding short-term risk, NUR.CN is more volatile compared to ET.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check ET.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, TSAT.TO has a market cap of 1.1B. Regarding current trading prices, NUR.CN is priced at CA$5.30, while TSAT.TO trades at CA$71.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas TSAT.TO's P/E ratio is -5.71. In terms of profitability, NUR.CN's ROE is +0.64%, compared to TSAT.TO's ROE of -0.29%. Regarding short-term risk, NUR.CN is less volatile compared to TSAT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUR.CN.Check TSAT.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, VCM.TO has a market cap of 324.4M. Regarding current trading prices, NUR.CN is priced at CA$5.30, while VCM.TO trades at CA$13.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas VCM.TO's P/E ratio is -27.79. In terms of profitability, NUR.CN's ROE is +0.64%, compared to VCM.TO's ROE of -0.06%. Regarding short-term risk, NUR.CN is more volatile compared to VCM.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check VCM.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, QTRH.TO has a market cap of 214.2M. Regarding current trading prices, NUR.CN is priced at CA$5.30, while QTRH.TO trades at CA$1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas QTRH.TO's P/E ratio is -2.81. In terms of profitability, NUR.CN's ROE is +0.64%, compared to QTRH.TO's ROE of -0.50%. Regarding short-term risk, NUR.CN is less volatile compared to QTRH.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUR.CN.Check QTRH.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, BYL.TO has a market cap of 39.7M. Regarding current trading prices, NUR.CN is priced at CA$5.30, while BYL.TO trades at CA$0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas BYL.TO's P/E ratio is -8.67. In terms of profitability, NUR.CN's ROE is +0.64%, compared to BYL.TO's ROE of +0.46%. Regarding short-term risk, NUR.CN is less volatile compared to BYL.TO. This indicates potentially lower risk in terms of short-term price fluctuations for NUR.CN.Check BYL.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, IMI.V has a market cap of 21.6M. Regarding current trading prices, NUR.CN is priced at CA$5.30, while IMI.V trades at CA$0.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas IMI.V's P/E ratio is 6.25. In terms of profitability, NUR.CN's ROE is +0.64%, compared to IMI.V's ROE of +0.71%. Regarding short-term risk, NUR.CN is less volatile compared to IMI.V. This indicates potentially lower risk in terms of short-term price fluctuations for NUR.CN.Check IMI.V's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, VTI.CN has a market cap of 1.5M. Regarding current trading prices, NUR.CN is priced at CA$5.30, while VTI.CN trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas VTI.CN's P/E ratio is -0.20. In terms of profitability, NUR.CN's ROE is +0.64%, compared to VTI.CN's ROE of -0.25%. Regarding short-term risk, NUR.CN is more volatile compared to VTI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check VTI.CN's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, MMAX.CN has a market cap of 92K. Regarding current trading prices, NUR.CN is priced at CA$5.30, while MMAX.CN trades at CA$0.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas MMAX.CN's P/E ratio is -0.40. In terms of profitability, NUR.CN's ROE is +0.64%, compared to MMAX.CN's ROE of +2.03%. Regarding short-term risk, NUR.CN is more volatile compared to MMAX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check MMAX.CN's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, SW.TO has a market cap of 0. Regarding current trading prices, NUR.CN is priced at CA$5.30, while SW.TO trades at CA$40.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas SW.TO's P/E ratio is N/A. In terms of profitability, NUR.CN's ROE is +0.64%, compared to SW.TO's ROE of -0.28%. Regarding short-term risk, NUR.CN is more volatile compared to SW.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check SW.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, AJX.TO has a market cap of 0. Regarding current trading prices, NUR.CN is priced at CA$5.30, while AJX.TO trades at CA$0.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas AJX.TO's P/E ratio is -11.04. In terms of profitability, NUR.CN's ROE is +0.64%, compared to AJX.TO's ROE of -0.20%. Regarding short-term risk, NUR.CN is more volatile compared to AJX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check AJX.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, EXF.TO has a market cap of 0. Regarding current trading prices, NUR.CN is priced at CA$5.30, while EXF.TO trades at CA$7.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas EXF.TO's P/E ratio is -55.75. In terms of profitability, NUR.CN's ROE is +0.64%, compared to EXF.TO's ROE of -0.06%. Regarding short-term risk, NUR.CN is more volatile compared to EXF.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check EXF.TO's competition here

NUR.CN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NUR.CN stands at 168.1M. In comparison, RDL.TO has a market cap of 0. Regarding current trading prices, NUR.CN is priced at CA$5.30, while RDL.TO trades at CA$0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NUR.CN currently has a P/E ratio of -0.15, whereas RDL.TO's P/E ratio is -2.05. In terms of profitability, NUR.CN's ROE is +0.64%, compared to RDL.TO's ROE of -0.48%. Regarding short-term risk, NUR.CN is more volatile compared to RDL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for NUR.CN.Check RDL.TO's competition here